Counterregulatory hormone release after human and porcine insulin in healthy subjects and patients with pituitary disorders
- 1 July 1984
- journal article
- research article
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 62 (14) , 659-668
- https://doi.org/10.1007/bf01716462
Abstract
Human and porcine insulin were administered intravenously to a group of healthy volunteers in two different doses (0.075 IU/kg body weight and 0.12 IU/kg body weight) and to two groups of randomly selected patients with pituitary disorders in a dose adapted to their individual glucose tolerance (0.12–0.17 IU/kg body weight for porcine and 0.15–0.18 IU/kg body weight for human insulin). The blood glucose and potassium lowering effect, the feedback regulation of endogenous insulin release, and the liberation of the counterregulatory hormones glucagon, cortisol, adrenocorticotropic hormone (ACTH), prolactin (hPRL), human growth hormone (hGH), and catecholamines were measured before and after injection of human or porcine insulin. The maximal effect, the area under the concentration-time curve, the percentage effect, and the increase above baseline for the two doses of insulin and the two types of insulin were compared. There were no significant differences in the calculated parameters between the two insulin types at the same doses except with prolactin. At 0.075 IU/kg human insulin induced significantly less prolactin release than porcine insulin. Comparing the two doses of the same insulin serum insulin levels, blood glucose, glucagon, norepinephrine, and prolactin were lower at the low dose of each insulin. In addition ACTH and epinephrine were also lower after human insulin at 0.075 IU/kg. The subjective signs of hypoglycemia were less pronounced after human insulin. It is concluded that the biological effects of human insulin are comparable to porcine insulin although prolactin release is significantly reduced after human insulin. If this difference is an indication of different receptor sensitivities for human and porcine insulin in the central nervous system and if the diminished signs of hypoglycemia are a consequence of this, then further studies are required.Keywords
This publication has 32 references indexed in Scilit:
- Comparison of Potency of Porcine Insulin and Semisynthetic Human Insulin at 3 Dose Levels Using the Euglycaemic ClampHormone and Metabolic Research, 1983
- Different Potencies of Biosynthetic Human and Purified Porcine InsulinHormone and Metabolic Research, 1983
- Lack of glucagon response to hypoglycemia in type I diabetics after long-term optimal therapy with a continuous subcutaneous insulin infusion pumpDiabetes, 1983
- HLA-DR-MT matching improves graft survival rate in cadaver kidney transplantationJournal of Molecular Medicine, 1983
- Severe Insulin-Induced Hypoglycemia Associated with Deficiencies in the Release of Counterregulatory HormonesNew England Journal of Medicine, 1981
- Chemical, Physical, and Biologic Properties of Biosynthetic Human InsulinDiabetes Care, 1981
- Does Insulin Play a Role in the Regulation of its Own Secretion?Hormone and Metabolic Research, 1978
- Problems in automation of serum cortisol radioimmunoassayAnalytical and Bioanalytical Chemistry, 1978
- Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamineLife Sciences, 1977
- Prolactin: A diabetogenic hormoneDiabetologia, 1977